SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
叶飞
Lv0
0 积分
2022-06-01 加入
最近求助
最近应助
互助留言
What’s next for the synthetic lethality drug discovery engine?
25天前
已完结
DGKα/ζ inhibitors combine with PD-1 checkpoint therapy to promote T cell–mediated antitumor immunity
4个月前
已完结
EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatment
5个月前
已完结
Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management
5个月前
已完结
Arginase 1 is a key driver of immune suppression in pancreatic cancer
6个月前
已完结
Arginase: An emerging and promising therapeutic target for cancer treatment
6个月前
已完结
Discovery of Polo-like Kinase 4 Inhibitors for the Treatment of Cancer: A Mini Patent Review
6个月前
已完结
Substrate and phosphorylation site selection by phosphoprotein phosphatases
7个月前
已完结
PTP1B is an intracellular checkpoint that limits T cell and CAR T cell anti-tumor immunity
7个月前
已完结
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity
7个月前
已完结
没有进行任何应助
谢谢
8个月前
谢谢
1年前
感谢
1年前
感谢
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论